Cargando…

An evaluation tool for myofascial adhesions in patients after breast cancer (MAP-BC evaluation tool): Development and interrater reliability

PURPOSE: To develop a tool to evaluate myofascial adhesions objectively in patients with breast cancer and to investigate its interrater reliability. METHODS: 1) Development of the evaluation tool. Literature was searched, experts in the field of myofascial therapy were consulted and pilot testing w...

Descripción completa

Detalles Bibliográficos
Autores principales: De Groef, An, Van Kampen, Marijke, Vervloesem, Nele, De Geyter, Sophie, Dieltjens, Evi, Christiaens, Marie-Rose, Neven, Patrick, Geraerts, Inge, Devoogdt, Nele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5466317/
https://www.ncbi.nlm.nih.gov/pubmed/28598978
http://dx.doi.org/10.1371/journal.pone.0179116
_version_ 1783243074244182016
author De Groef, An
Van Kampen, Marijke
Vervloesem, Nele
De Geyter, Sophie
Dieltjens, Evi
Christiaens, Marie-Rose
Neven, Patrick
Geraerts, Inge
Devoogdt, Nele
author_facet De Groef, An
Van Kampen, Marijke
Vervloesem, Nele
De Geyter, Sophie
Dieltjens, Evi
Christiaens, Marie-Rose
Neven, Patrick
Geraerts, Inge
Devoogdt, Nele
author_sort De Groef, An
collection PubMed
description PURPOSE: To develop a tool to evaluate myofascial adhesions objectively in patients with breast cancer and to investigate its interrater reliability. METHODS: 1) Development of the evaluation tool. Literature was searched, experts in the field of myofascial therapy were consulted and pilot testing was performed. 2) Thirty patients (63% had a mastectomy, 37% breast-conserving surgery and 97% radiotherapy) with myofascial adhesions were evaluated using the developed tool by 2 independent raters. The Weighted Kappa (WK) and the intra-class correlation coefficient (ICC) were calculated. RESULTS: 1) The evaluation tool for Myofascial Adhesions in Patients with Breast Cancer (MAP-BC evaluation tool) consisted of the assessment of myofascial adhesions at 7 locations: axillary and breast region scars, musculi pectorales region, axilla, frontal chest wall, lateral chest wall and the inframammary fold. At each location the degree of the myofascial adhesion was scored at three levels (skin, superficial and deep) on a 4-points scale (between no adhesions and very stiff adhesions). Additionally, a total score (0–9) was calculated, i.e. the sum of the different levels of each location. 2) Interrater agreement of the different levels separately was moderate for the axillary and mastectomy scar (WK 0.62–0.73) and good for the scar on the breast (WK >0.75). Moderate agreement was reached for almost all levels of the non-scar locations. Interrater reliability of the total scores was the highest for the scars (ICC 0.82–0.99). At non-scar locations good interrater reliability was reached, except for the inframammary fold (ICC = 0.71). CONCLUSIONS: The total scores of all locations of the MAP-BC evaluation tool had good to excellent interrater reliability, except for the inframammary fold which only reached moderate reliability.
format Online
Article
Text
id pubmed-5466317
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-54663172017-06-22 An evaluation tool for myofascial adhesions in patients after breast cancer (MAP-BC evaluation tool): Development and interrater reliability De Groef, An Van Kampen, Marijke Vervloesem, Nele De Geyter, Sophie Dieltjens, Evi Christiaens, Marie-Rose Neven, Patrick Geraerts, Inge Devoogdt, Nele PLoS One Research Article PURPOSE: To develop a tool to evaluate myofascial adhesions objectively in patients with breast cancer and to investigate its interrater reliability. METHODS: 1) Development of the evaluation tool. Literature was searched, experts in the field of myofascial therapy were consulted and pilot testing was performed. 2) Thirty patients (63% had a mastectomy, 37% breast-conserving surgery and 97% radiotherapy) with myofascial adhesions were evaluated using the developed tool by 2 independent raters. The Weighted Kappa (WK) and the intra-class correlation coefficient (ICC) were calculated. RESULTS: 1) The evaluation tool for Myofascial Adhesions in Patients with Breast Cancer (MAP-BC evaluation tool) consisted of the assessment of myofascial adhesions at 7 locations: axillary and breast region scars, musculi pectorales region, axilla, frontal chest wall, lateral chest wall and the inframammary fold. At each location the degree of the myofascial adhesion was scored at three levels (skin, superficial and deep) on a 4-points scale (between no adhesions and very stiff adhesions). Additionally, a total score (0–9) was calculated, i.e. the sum of the different levels of each location. 2) Interrater agreement of the different levels separately was moderate for the axillary and mastectomy scar (WK 0.62–0.73) and good for the scar on the breast (WK >0.75). Moderate agreement was reached for almost all levels of the non-scar locations. Interrater reliability of the total scores was the highest for the scars (ICC 0.82–0.99). At non-scar locations good interrater reliability was reached, except for the inframammary fold (ICC = 0.71). CONCLUSIONS: The total scores of all locations of the MAP-BC evaluation tool had good to excellent interrater reliability, except for the inframammary fold which only reached moderate reliability. Public Library of Science 2017-06-09 /pmc/articles/PMC5466317/ /pubmed/28598978 http://dx.doi.org/10.1371/journal.pone.0179116 Text en © 2017 De Groef et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
De Groef, An
Van Kampen, Marijke
Vervloesem, Nele
De Geyter, Sophie
Dieltjens, Evi
Christiaens, Marie-Rose
Neven, Patrick
Geraerts, Inge
Devoogdt, Nele
An evaluation tool for myofascial adhesions in patients after breast cancer (MAP-BC evaluation tool): Development and interrater reliability
title An evaluation tool for myofascial adhesions in patients after breast cancer (MAP-BC evaluation tool): Development and interrater reliability
title_full An evaluation tool for myofascial adhesions in patients after breast cancer (MAP-BC evaluation tool): Development and interrater reliability
title_fullStr An evaluation tool for myofascial adhesions in patients after breast cancer (MAP-BC evaluation tool): Development and interrater reliability
title_full_unstemmed An evaluation tool for myofascial adhesions in patients after breast cancer (MAP-BC evaluation tool): Development and interrater reliability
title_short An evaluation tool for myofascial adhesions in patients after breast cancer (MAP-BC evaluation tool): Development and interrater reliability
title_sort evaluation tool for myofascial adhesions in patients after breast cancer (map-bc evaluation tool): development and interrater reliability
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5466317/
https://www.ncbi.nlm.nih.gov/pubmed/28598978
http://dx.doi.org/10.1371/journal.pone.0179116
work_keys_str_mv AT degroefan anevaluationtoolformyofascialadhesionsinpatientsafterbreastcancermapbcevaluationtooldevelopmentandinterraterreliability
AT vankampenmarijke anevaluationtoolformyofascialadhesionsinpatientsafterbreastcancermapbcevaluationtooldevelopmentandinterraterreliability
AT vervloesemnele anevaluationtoolformyofascialadhesionsinpatientsafterbreastcancermapbcevaluationtooldevelopmentandinterraterreliability
AT degeytersophie anevaluationtoolformyofascialadhesionsinpatientsafterbreastcancermapbcevaluationtooldevelopmentandinterraterreliability
AT dieltjensevi anevaluationtoolformyofascialadhesionsinpatientsafterbreastcancermapbcevaluationtooldevelopmentandinterraterreliability
AT christiaensmarierose anevaluationtoolformyofascialadhesionsinpatientsafterbreastcancermapbcevaluationtooldevelopmentandinterraterreliability
AT nevenpatrick anevaluationtoolformyofascialadhesionsinpatientsafterbreastcancermapbcevaluationtooldevelopmentandinterraterreliability
AT geraertsinge anevaluationtoolformyofascialadhesionsinpatientsafterbreastcancermapbcevaluationtooldevelopmentandinterraterreliability
AT devoogdtnele anevaluationtoolformyofascialadhesionsinpatientsafterbreastcancermapbcevaluationtooldevelopmentandinterraterreliability
AT degroefan evaluationtoolformyofascialadhesionsinpatientsafterbreastcancermapbcevaluationtooldevelopmentandinterraterreliability
AT vankampenmarijke evaluationtoolformyofascialadhesionsinpatientsafterbreastcancermapbcevaluationtooldevelopmentandinterraterreliability
AT vervloesemnele evaluationtoolformyofascialadhesionsinpatientsafterbreastcancermapbcevaluationtooldevelopmentandinterraterreliability
AT degeytersophie evaluationtoolformyofascialadhesionsinpatientsafterbreastcancermapbcevaluationtooldevelopmentandinterraterreliability
AT dieltjensevi evaluationtoolformyofascialadhesionsinpatientsafterbreastcancermapbcevaluationtooldevelopmentandinterraterreliability
AT christiaensmarierose evaluationtoolformyofascialadhesionsinpatientsafterbreastcancermapbcevaluationtooldevelopmentandinterraterreliability
AT nevenpatrick evaluationtoolformyofascialadhesionsinpatientsafterbreastcancermapbcevaluationtooldevelopmentandinterraterreliability
AT geraertsinge evaluationtoolformyofascialadhesionsinpatientsafterbreastcancermapbcevaluationtooldevelopmentandinterraterreliability
AT devoogdtnele evaluationtoolformyofascialadhesionsinpatientsafterbreastcancermapbcevaluationtooldevelopmentandinterraterreliability